Use of the multiple sclerosis Functional Composite to predict disability in relapsing MS

To determine whether the MS Functional Composite (MSFC) can predict future disease progression in patients with relapsing remitting MS (RR-MS). The MSFC was recommended by the Clinical Outcomes Assessment Task Force of the National MS Society as a new clinical outcome measure for clinical trials. Th...

Full description

Saved in:

Bibliographic Details
Published in:	Neurology Vol. 56; no. 10; pp. 1324 - 1330
Main Authors:	RUDICK, R. A, CUTTER, G, BAIER, M, FISHER, E, DOUGHERTY, D, WEINSTOCK-GUTTMAN, B, MASS, M. K, MILLER, D, SIMONIAN, N. A
Format:	Journal Article
Language:	English
Published:	Hagerstown, MD Lippincott Williams & Wilkins 22-05-2001
Subjects:	Adult Atrophy - pathology Atrophy - physiopathology Biological and medical sciences Brain - pathology Brain - physiopathology Clinical Trials, Phase III as Topic Disability Evaluation Female Health Status Humans Interferon beta-1a Interferon-beta - administration & dosage Interferon-beta - adverse effects Magnetic Resonance Imaging Male Medical sciences Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis Multiple Sclerosis, Relapsing-Remitting - drug therapy Multiple Sclerosis, Relapsing-Remitting - pathology Multiple Sclerosis, Relapsing-Remitting - physiopathology Neurology Predictive Value of Tests Prognosis Reproducibility of Results Surveys and Questionnaires Treatment Outcome Handicap Human Nervous system diseases Multiple sclerosis Prognosis Central nervous system disease Recurrent Inflammatory disease
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!